Radiology Positioning Aids Market Size Worth $359.1 Million By 2026

The global radiology positioning aids market size is expected to reach USD 359.1 million by 2026, according to a new report by Grand View Research, Inc., registering a 5.7% CAGR during the forecast period. Increasing cases of bone fractures, along with growing prevalence of cancer, tumors, and other digestive conditions, is expected to drive the overall market.

North America was identified as the dominant region in 2018 in terms of market share and is expected to grow at a significant pace throughout the forecast period. The increasing momentum observed in this region is largely attributed to growing geriatric population, who are prone to fractures, and increasing product demand in hospitals.

Frequent introduction of innovative positioning aids are expected to impact the market dynamics during the forecast period. Introduction of advanced imaging systems boosts demand for newer types of positioning aids. Increasing number of standalone radiology centers in developing countries is expected to fuel the market.

Growing partnerships among players and suppliers to increase the reach of these products is expected to result in increased penetration and availability of these products. Moreover, courses for radiology and positioning is also expected to drive the radiology positioning aids market during forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/radiology-positioning-aids-market

Further key findings from the report suggest:

The wedge X-ray segment is predicted to register significant growth over the forecast period owing its advance angled design that helps in providing proper image along with enhanced patient comfort
Head, neck, and brain related devices are anticipated to hold maximum share in the forthcoming years due to growing number of cases associated with these anatomy
Hospitals is anticipated to hold a larger share in radiology positioning aids market owing to growing adoption of different advanced X-ray or radiology devices such as X-ray devices with different material such as polyurethrane
Asia Pacific is anticipated to witness considerable growth over the forecast period due to improving healthcare facilities and adoption of advanced imaging devices for proper diagnosis
Major market players include Bionix Radiation Therapy; CIVCO Radiotherapy; AADCO Medical, Inc.; IZI Medical Products; Varian Medical Systems, Inc.; Elekta AB; VERTEC LTD.; and Klarity Medical Products. These players are focusing on expanding their distribution network by forming associations with suppliers.

Spine Biologics Market Size Worth $2.5 Billion By 2026

The global spine biologics market size is expected to reach USD 2.5 billion by 2026, according to a new report by Grand View Research, Inc., registering a 4.2% CAGR over the forecast period. The market is primarily driven by increasing incidence of spinal injuries. Prevalence of spinal deformities has been on a rise in developed and underdeveloped countries and this has resulted in an increase in the number of surgeries being carried. This has had a positive impact on the market for spine biologics.

Apart from this, growing awareness about numerous advantages of biologics in spine fusion surgeries, such as minimal postoperative time and ability to activate cellular growth, has also propelled the market. Biomaterials and bone graft substitutes are being adopted as the choice of treatment for spinal deformities. Increasing percentage of the elderly population suffering from spinal disorders and rising adoption of these products as a treatment method is anticipated to boost the market for spine biologics over the forecast period.

The geriatric population is more prone to spondylolisthesis and degeneration of disc. This, coupled with increasing number of trauma cases due to road accidents and sports injuries, is driving demand for spine biologics. According to the Open Access Journal for Minimally Invasive Surgery (MIS) published in 2018, minimally invasive techniques are being adopted for the treatment of a wide range of spine pathologies. Approximately 400,000 cases are performed in the U.S. annually and spine fusion has turned out to be one of the most commonly performed and well-established treatment options for spine trauma, degenerative disorders, tumors, and structural abnormalities.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/spine-biologics-market

Further key findings from the report suggest:

Many clinicians consider spinal allografts as the gold standard for spinal fusion. The use of biologics influences surgical outcomes as it helps in improving fusion rates and reducing pain. This driven the segment to account for the dominant revenue share
Hospitals held the leading share in terms of end use in 2018 owing to availability of highly skilled professionals and increasing number of spine surgeries performed. Ambulatory Surgery Centers (ASC), on the other hand, are anticipated to witness lucrative growth over the forecast period
North America captured the largest share in the market in 2018, owing to presence of well-established healthcare infrastructure, high awareness among surgeons pertinent to bone graft procedures, and availability of favorable reimbursement policies
Asia Pacific is anticipated to show significant growth through 2026. Booming medical tourism industry offering advanced healthcare services at affordable costs is the key factor driving the regional spine biologics market
Some of the key companies are Stryker; Orthofix International N.V.; K2M Inc.; Exactech Inc.; Wright Medical Technology Inc.; DePuy Synthes Companies; Zimmer Holding Inc.; Nuvasive Inc.; and Medtronic Inc. Strategic acquisitions and presence of new entrants are making the market immensely competitive.

Medical Protective Clothing Market Size Worth $661.0 Million By 2027

The global medical protective clothing market size is expected to reach USD 661.0 million by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 7.4% from 2020 to 2027. Increasing demand for medical protective clothing to ensure employees’ safety during the ongoing COVID-19 pandemic is expected to boost market growth.

Stringent government regulations pertaining to employee safety are forcing employers to comply with the industry standards, thereby augmenting the product demand. Furthermore, shifting customer preference towards better performing, comfortable, and stylish clothing is driving the companies to invest significantly in research & development activities.

Increasing number of COVID-19 cases in the economies, including Italy, China, and U.S., coupled with insufficient supply of protective kits, is likely to drive product demand. Implementation of the Defense Production Act (DPA) by U.S. has resulted in other apparel manufacturers focusing on the production of protective clothing, thereby complementing growth.

Fashion conglomerates, luxury labels, and designers are engaged in the production of protective clothing for providing protection to the personnel exposed to the COVID-19 virus. In addition, various small-scale companies are involved in providing alternative solutions, such as disposable or reusable laboratory coats and aprons with long sleeves and snaps or buttons for fastening.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/medical-protective-clothing-market

Further key findings from the report suggest:

In U.S., the home healthcare segment is estimated to reach USD 39.4 million by 2027 on account of increasing demand for an inexpensive and effective alternative to hospitalization by the elderly population
In Europe, coveralls are expected to expand at a CAGR of 6.3% from 2020 to 2027 in terms of revenue owing to stringent regulations in the region pertaining to the health and safety of the healthcare professionals
In India, gowns accounted for 39.9% share of the overall revenue in 2019 owing to their ability to minimize the risk of disease transmission by the healthcare professionals, coupled with the low-level of stress/heat generated by the garment
North America accounted for 28.7% share of the global revenue in 2019 on account of increasing investments in the healthcare industry, along with rising prevalence of chronic diseases in the region
Key manufactures such as Kimberly-Clark Worldwide, Inc., 3M, Honeywell, and Ansell are focused on supplying protective clothing to the healthcare professionals (HCPs) in response to the COVID-19 pandemic.

Surgical Blades Market Worth $181.20 Million By 2026

The global surgical blade market size is anticipated to reach USD 181.2 million by 2026, as per a new report by Grand View Research, Inc., exhibiting a CAGR of 3.6% over the forecast period. Increase in surgeries due to increase in number of accidents, coupled with a growing geriatric population prone to various disorders, is currently driving the market. Moreover, increase in number of surgeons at a global scale is also propelling the demand for surgical blades.

Several key players are investing in R&D to launch new and innovative products. Increase in individual disposable income & standard of living, and growth in awareness regarding modern surgical procedures are other factors increasing the number of medical procedures. Increase in trauma cases and other disorders, such as cancer, which require surgery, is further augmenting demand for surgical blades. Furthermore, availability of these blades in various shapes and sizes for surgical intervention in multiple illnesses is driving the overall market.

With a wide range of procedures in healthcare, more patients are willing to undergo new treatments due to improving affordability and feasibility. Stainless steel blades are increasingly preferred due to features such as cleaner incisions, superior cutting, and numbering of scalpel handles. Being low-risk medical tools, these products do not need strict regulatory processes, which encourages and eases product launches.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/surgical-blades-market

Further key findings from the report suggest:

Surgical blades come in a variety of forms, enabling surgeons and medical staff to choose the right blade for a medical procedure
By product, stainless steel blades are expected to lead market over the forecast period, due to better anti-corrosion properties. They are more suitable for procedures involving large volumes of saline solution and multiple incisions
By material, sterile blades are expected to dominate the market since they can provide a sharp cutting edge for high efficiency, enabling cleaner incisions and superior cutting
By end use, hospitals segment accounted for a share of over 40.0% and is expected to grow at a CAGR of 3.7% over the forecast period
Some key players of surgical blades market are Swann-Morton Limited; PL Medical Co.; Hill-Rom, LLC; Beaver-Visitec International; VOGT Medical; Hu-Friedy Mfg. Co., LLC; B. Braun Melsungen AG; and Surgical Specialties Corporation.

Elastography Imaging Market Worth $3.5 Billion By 2026

The global elastography imaging market size is expected to reach USD 3.5 billion by the end of 2026, according to a new report by Grand View Research, Inc., registering a 7.8% CAGR over the forecast period. Increasing incidence of breast cancer and chronic liver disorders is expected to significantly drive the market. Additionally, increasing demand for minimally-invasive procedures and ongoing studies to assess the potential applications of elastography are factors expected to contribute toward rapid growth.

Currently elastography has wide applications in assessing breasts, thyroid, prostate, and liver. Increasing number of ongoing studies are expected to increase its applications in diagnosis of various conditions such neurodegenerative disorders and chronic kidney diseases. It has shown promising results for its use in assessment of kidney health during and after transplantation.

North America dominated the market in 2018 and is expected to continue its dominance during the forecast period. The elastography imaging market growth observed in the region is due to the presence of a large number of global players, along with high adoption rate for advanced imaging techniques.

Growing strategic alliances among players for development and distribution of products is expected to propel the market during the forecast period. Moreover, development of new surgical centers in different locations will increase the adoption of advanced imaging systems.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/elastography-imaging-market

Further key findings from the report suggest:

By modality, the ultrasound segment is predicted to register significant growth during the forecast period owing to advantages such as low price, accessibility, and high degree of measurement for tissue deformation
On the basis of end use, the hospital segment is anticipated to hold the largest share in the market during the forecast period due to rising number of ultrasound and MRI-based elastography procedures and growing trends of hospital-based imaging facilities
By way of application, the radiology domain is predicted to hold a large share in the market over the forecast period owing to increase in demand in image-guided radiotherapy and radiology ultrasound
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to improving healthcare facilities and rising geriatric population who are prone to developing targeted disorders
Major players in the elastography imaging industry are focusing on growth strategies such as partnerships, collaborations, mergers, and acquisitions. Some of the leading players are Esaote SpA; Canon Medical Systems Corporation; Koninklijke Philips N.V.; Hitachi, Ltd.; GE Healthcare; Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthineers; Toshiba America Medical Systems, Inc.; and Samsung Medison Co., Ltd.

Ophthalmic Knife Market Size Worth $2.4 Billion By 2026

The global ophthalmic knives market size is expected to reach USD 2.4 Billion by 2026, as per a new report by Grand View Research Inc. It is projected to register a CAGR of 4.9% during the forecast period. Introduction of advanced knives and rising incidence of age related ophthalmic diseases are some of the major factors driving the growth.

Increasing overall life expectancy and rising geriatric population is expected to cause steep increase in age related ophthalmic disorders. Along with these, incidence of lifestyle associated ophthalmic devices including myopia and hypermetropia are expected showcase significant growth during the forecast period. Most of these ophthalmic conditions cannot be treated by drugs. Increasing number of ophthalmic surgeries are expected to boost the market during forecast period.

High competition and introduction of local players are the factors encouraging market players to introduce advanced knives at affordable prices. Major players are focusing on developing innovative manufacturing techniques along with advanced raw materials to reduce the device price.

Incorporation of new reimbursement policies in developed countries along with growing efforts of non-profit organizations to increase awareness about ophthalmic conditions and to provide affordable/free ophthalmic procedures in rural regions are the factors expected to boost the number of ophthalmic surgeries.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/ophthalmic-knives-market

Further key findings from the report suggest:

North America captured the largest ophthalmic knife industry share in 2018 owing to favorable reimbursement policies, presence of major market players, and rise in geriatric population
Straight knives segment is anticipated to expand at a CAGR of 4.10% during the forecast period owing to fine design, durability, and sharpness of the knives
Slit knives segment is also expected to register lucrative CAGR in near future owing to extensive use for entry in anterior chamber/phaco stab incision (single bevel) in eye-related surgeries
Single-use/disposable knives segment is expected to witness significant growth over the forecast period due to features such as safety and affordability
The key players profiled in the ophthalmic knife market comprise Alcon, Inc.; Hoya Corporation; Essilor; Topcon Corporation; Hai Laboratories, Inc.; Bausch and Lomb Incorporated; MANI Inc.; Seiko Optical Products Co., Ltd.; Nidek Co., Ltd.; Ziemer Group; Alltion; and DGH Technology

Continuous Subcutaneous Insulin Infusion Market Size Worth $7.3 Billion By 2027

The global continuous subcutaneous insulin infusion market size is expected to reach USD 7.3 billion by 2027, registering a CAGR of 10.3% over the forecast period, according to a new report by Grand View Research, Inc. The key drivers of the market include increasing number of diabetes population coupled with technological advancement in the field of diabetes care.

According to International Diabetes Federation (IDF), the total number of diabetic population is expected to grow by 51.0% from 463.0 million in 2019 to 700.0 million in 2045. Rising health expenditure and growing awareness about preventive care is expected to boost market growth. According to the IDF, the estimated total global health expenditure to diabetes was USD 760.0 billion and is projected to grow to USD 845.0 billion by 2045. Furthermore, rising government initiatives to spread the awareness about diabetes is propelling the adoption of advanced diabetes management devices. Australian government launched Australian National Diabetes Strategy 2016 to 2020. The strategy aims to trace country’s national response to this epidemic and inform how existing limited healthcare can be better targeted across all level of government.

Increasing number of product launches and advent of artificial intelligence in the market is boosting the growth. Many startups are transforming CSII therapy. These companies are taking initiatives to lessen the burden of diabetes with help of AI technology. They are leveraging technological advancement to improve market solutions like integrated insulin pumps, non-invasive insulin delivery systems, and closed-loop artificial pancreases.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/continuous-subcutaneous-insulin-infusion-market

Further key findings from the study suggest:

North America accounted for the largest share in 2019 owing to favorable reimbursement policies, presence of key players, and frequent product launches
Asia Pacific is expected to see robust growth during the forecast period owing to presence of large diabetic population
By product, tethered pumps dominated the market owing to availability of products
By patient type, type 1 patients account for the largest share owing wide usage of insulin pumps
By end use, the hospitals segment dominated the market in 2019 and the homecare segment is expected to grow at a fastest pace
The market is highly competitive owing to continuous technological advancement and many innovative product launches.

Endotracheal Tubes Market Size Worth $2.9 Billion By 2027

The global endotracheal tubes market size is expected to reach USD 2.9 billion by 2027, expanding at a CAGR of 6.0%, according to a new report by Grand View Research, Inc. The rising prevalence of chronic diseases such as respiratory, cardiovascular diseases, and increasing number of surgical procedures, are expected to propel market growth. In addition, technological development in the medical device is further expected to contribute to market growth during forecast period. Recently Medtronic has launched a Shiley laser oral endotracheal tubes that are most widely used for ventilation during CO2 and KTP laser surgeries of the laryngeal or tracheal area.

Moreover, growing need for ventilator associated with pneumonia and increasing geriatric population that are prone to chronic diseases is one of the important factors responsible for market growth during assessment period. As per World Health Organization Report 2019, 4.0 million people die prematurely due to chronic respiratory disease. Due to increasing air pollution the prevalence of respiratory diseases is also increasing. According to World Health Organization Report 2019, around 2.0 billion people are exposed to indoor toxic, 1.0 billion people are exposed to outdoor pollutant air, and around 1.0 billion people are exposed to tobacco smoke. Above factors are likely to boost market growth. In addition, increasing awareness about technologically advanced medical devices, and developments in the field of nano biotechnology and drug design are some of the factors responsible for market growth.

North America accounted for the highest market share in 2019 owing to the advanced healthcare system and the growing prevalence of chronic diseases in the country. In addition, the presence of major players in the region contributed to market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/endotracheal-tubes-market

Further Key Findings From the Report Suggest:

By product type, the regular endotracheal tube segment held the largest market share of 32% in 2019 owing to increasing prevalence of respiratory diseases
Orotracheal segment held the largest market share accounted for 64% in 2019 owing to its high applicability, increased usage and comfortability
North America dominated the market in 2019. Rising prevalence of chronic respiratory disease is one of the major factors driving the market growth in this region
Asia Pacific is expected to witness the fastest growth over the forecast period. As the healthcare infrastructure in the region is developing resulting in increased number of surgeries being performed and eventually fueling the growth of the market.

Continuous Glucose Monitoring Device Market Worth $10.4 Billion By 2027

The global continuous glucose monitoring device market size is expected to reach USD 10.4 billion by 2027, according to a new report by Grand View Research, Inc. The market is estimated to register a CAGR of 12.7% over the forecast period. Growing cases of diabetes and introduction of novel and advanced diabetes care devices are the major factors driving the market growth. Continuous glucose monitoring devices provide an efficient method to measure body glucose levels in real time. Data recorded by these devices is transmitted through a wireless network to receivers; this helps keep a track of glucose levels over a designated period.

These devices also help manage diabetes while reducing individual insulin dosages. Integrated software within these devices provides users with insights about food consumption, medication, physical activity, and illnesses. Thus, an increasing number of diabetic patients are using these devices to manage and treat diabetes, which, in turn, is accelerating market growth. With the advent of digital therapeutics, a rising number of continuous glucose monitoring devices are being incorporated with apps and software to help patients with diabetes mellitus. Rise in the number of diabetes mellitus has been contributing toward continuous glucose monitoring (CGM) systems market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/continuous-glucose-monitoring-market

Further key findings from the study suggest:

Growing cases of diabetes is anticipated to propel market growth, with increasing number of patients opting for simplified CGM devices
CGM devices provide analysis of blood glucose levels from the tissue fluid at regular intervals of time, which is also driving their demand
Sensors was the largest component type segment and is anticipated to maintain its dominance owing to their integral nature in these devices
Asia Pacific is the leading regional continuous glucose monitoring device market, with Japan, China, and India on the forefront
North America led the global market in the past owing to wide usage of CGM devices as a result of higher number of target patients in the region
The European region followed the North American closely in terms of market revenue due to rise in the adoption of these devices in key countries such as U.K., Germany, France, Italy, and Spain
Some of the key companies present in the market are Pfizer Inc.; Baxter International, Inc.; Abbott Laboratories; Medtronic PLC; Animas Corporation; and Novo Nordisk A/S.

Blood Transfusion Diagnostics Market Size Worth $5.8 Billion By 2027

The global blood transfusion diagnostics market size is expected to reach a value of USD 5.8 billion by 2027 registering a CAGR of 6.6%, according to a new report by Grand View Research, Inc. Growing prevalence of chronic diseases, such as anemia, sickle cell disease, hemophilia, cancer, and kidney disease, is significantly driving the market growth. According to the Sickle Cell Disease Coalition statistics, globally, the number of sickle cell disease cases is projected to increase by around 30% by 2050.According to NCBI statistics, liver diseases accounts for around 2 million deaths each year globally. Blood transfusion is crucial for patients with such chronic diseases, as it allows to exchange the diseased cells with the healthy RBCs without disrupting the blood viscosity.

Female transfused holding a tablet computer in hospital ward

According to the National Blood Transfusion Service (NBTS) database, a total of 60,236 donor screening was done between 2010 and 2016 at the National Blood Transfusion Center (NBTC), Eritrea. Among them, at least 3.6% of the donated blood showed positive results for TTI and 0.1% showed positive results for multiple infections. Some of the chronic infectious diseases, such as hepatitis B, hepatitis C, HIV, and syphilis, create the need for accurate donor screening, thus further driving the market growth of diagnostics. Transfusion is commonly used in cases of trauma, road accidents, surgeries, childbirth, and gastrointestinal bleeding to replace major blood losses.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/blood-transfusion-diagnostics-market

Further key findings from the report suggest:

Reagents and kits is expected to be the largest as well as the fastest-growing product segment from 2020 to 2027
The disease screening segment is projected to register the fastest CAGR over the forecast period
According to the WHO, screening of donated blood for detecting transfusion transmissible infections, such as hepatitis B & C and HIV, should be mandatory
The hospitals end-use segment is estimated to account for the second largest market share by 2027 on account of rising instances of Pretransfusion therapies being performed in hospitals as the therapy requires cross-matching tests between the donor and recipient
Asia Pacific is projected to be the fastest-growing regional market due to rising geriatric population, especially in China and Japan